RANKL Is a Downstream Mediator for Insulin-Induced Osteoblastic Differentiation of Vascular Smooth Muscle Cells
Open Access
- 15 December 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (12), e29037
- https://doi.org/10.1371/journal.pone.0029037
Abstract
Several reports have shown that circulating insulin level is positively correlated with arterial calcification; however, the relationship between insulin and arterial calcification remains controversial and the mechanism involved is still unclear. We used calcifying vascular smooth muscle cells (CVSMCs), a specific subpopulation of vascular smooth muscle cells that could spontaneously express osteoblastic phenotype genes and form calcification nodules, to investigate the effect of insulin on osteoblastic differentiation of CVSMCs and the cell signals involved. Our experiments demonstrated that insulin could promote alkaline phosphatase (ALP) activity, osteocalcin expression and the formation of mineralized nodules in CVSMCs. Suppression of receptor activator of nuclear factor κB ligand (RANKL) with small interfering RNA (siRNA) abolished the insulin-induced ALP activity. Insulin induced the activation of extracellular signal-regulated kinase (ERK)1/2, mitogen-activated protein kinase (MAPK) and RAC-alpha serine/threonine-protein kinase (Akt). Furthermore, pretreatment of human osteoblasts with the ERK1/2 inhibitor PD98059, but not the phosphoinositide 3-kinase (PI3K) inhibitor, LY294002, or the Akt inhibitor, 1L-6-hydroxymethyl-chiro-inositol 2-(R)-2-O-methyl-3-O-octadecylcarbonate (HIMO), abolished the insulin-induced RANKL secretion and blocked the promoting effect of insulin on ALP activities of CVSMCs. Recombinant RANKL protein recovered the ALP activities decreased by RANKL siRNA in insulin-stimulated CVSMCs. These data demonstrated that insulin could promote osteoblastic differentiation of CVSMCs by increased RANKL expression through ERK1/2 activation, but not PI3K/Akt activation.This publication has 41 references indexed in Scilit:
- The RANKL/RANK/OPG Signaling Pathway Mediates Medial Arterial Calcification in Diabetic Charcot NeuroarthropathyDiabetes, 2011
- Apelin Attenuates the Osteoblastic Differentiation of Vascular Smooth Muscle CellsPLOS ONE, 2011
- PKA-induced Receptor Activator of NF-κB Ligand (RANKL) Expression in Vascular Cells Mediates Osteoclastogenesis but Not Matrix CalcificationPublished by Elsevier BV ,2010
- Concomitant insulin resistance and impaired vascular function is associated with increased coronary artery calcificationInternational Journal of Cardiology, 2010
- Arterial stiffness and the autonomic nervous system during the development of Zucker diabetic fatty ratsDiabetes & Metabolism, 2009
- Connective tissue growth factor is a downstream mediator for preptin-induced proliferation and differentiation in human osteoblastsAmino Acids, 2009
- Coronary Artery Calcification, ADMA, and Insulin Resistance in CKD PatientsClinical Journal of the American Society of Nephrology, 2008
- Adipokines, Insulin Resistance, and Coronary Artery CalcificationJournal of the American College of Cardiology, 2008
- Osteoprotegerin Inhibits Vascular Calcification Without Affecting Atherosclerosis in
ldlr
(−/−)
MiceCirculation, 2008
- Insulin attenuates vascular smooth muscle calcification but increases vascular smooth muscle cell phosphate transportAtherosclerosis, 2007